SHINE Medical is a company that will manufacture the medical isotope Mo-99 which is used in the diagnosis of the two biggest killers of Americans today: both heart disease and cancer. SHINE plans to build a plant in Janesville, WI to produce Mo-99 without the use of a nuclear reactor (the only current source for the isotopes). Over the course of its lifetime, it is expected that the products from this facility will have a positive impact on the lives of over 1 billion people. SHINE’s technology is greener, safer, and cheaper than existing production methods and addresses a massive and emerging global need.
For more information about SHINE Medical, see the news links below: